Rabiya S Tuma. Show Affiliations »
Abstract
Mesh： See more » Antineoplastic Agents/therapeutic useBenzenesulfonates/administration & dosageClinical Trials, Phase II as Topic/standardsClinical Trials, Phase III as Topic/standardsConfounding Factors, EpidemiologicHumansNeoplasms/drug therapyNiacinamide/analogs & derivativesPhenylurea CompoundsPyridines/administration & dosageRandomized Controlled Trials as Topic/standardsResearch DesignSorafenibTreatment Outcome
Substances： See more » Antineoplastic AgentsBenzenesulfonatesPhenylurea CompoundsPyridinesNiacinamideSorafenib
Year: 2008 PMID： 18230788 DOI： 10.1093/jnci/djn006
Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506